About the Authors
- Ana L. Alessandri
-
Affiliation Medical Research Council Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Rodger Duffin
-
* E-mail: rodger.duffin@ed.ac.uk
Affiliation Medical Research Council Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Andrew E. Leitch
-
Affiliation Medical Research Council Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Christopher D. Lucas
-
Affiliation Medical Research Council Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Tara A. Sheldrake
-
Affiliation Medical Research Council Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- David A. Dorward
-
Affiliation Medical Research Council Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Nik Hirani
-
Affiliation Medical Research Council Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Vanessa Pinho
-
Affiliation Imunofarmacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
- Lirlândia Pires de Sousa
-
Affiliation Imunofarmacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
- Mauro M. Teixeira
-
Affiliation Imunofarmacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
- John F. Lyons
-
Affiliation Astex Therapeutics, Cambridge, England, United Kingdom
- Christopher Haslett
-
Affiliation Medical Research Council Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
- Adriano G. Rossi
-
Affiliation Medical Research Council Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom
Competing Interests
The authors have read the journal's policy and have the following conflict: The authors have a non-financial academic link with Astex Therapeutics who kindly gifted them with the cyclin-dependent kinase inhibitor, AT7519. This compound is also commercially available (Selleck). This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ALA RD AGR. Performed the experiments: ALA RD AEL CDL TAS DAD. Analyzed the data: ALA RD CDL. Contributed reagents/materials/analysis tools: JFL. Wrote the paper: ALA RD AEL CDL CH AGR. Intellectual input into study design and manuscript editing: NH VP LPdS MMT.